Town Square

Post a New Topic

The cost of COVID-19 drug remdesivir: $2,340 to $3,120 per patient

Original post made on Jul 1, 2020

Gilead Sciences, the manufacturer of an experimental antiviral drug used to shorten COVID-19's effects, announced on Monday costs for remdesivir, which it claims is far below how drugs are usually priced.

Read the full story here Web Link posted Tuesday, June 30, 2020, 3:55 PM

Comments (1)

2 people like this
Posted by Steve Taffee
a resident of Menlo Park: The Willows
on Jul 1, 2020 at 5:18 pm

In situations like this I believe that the Federal Government has a role in bringing the price down even further by allowing generics to enter the market for this particular use of remdesivir in treating patients with COVID 19.

Created in 2009 I suspect (but may be off-base here) that Gillead has recouped much of its original investment. Even if this is not the case, it is in the public interest to distribute as much of it as cheaply as possible around the world. The U.S. ha already purchased 500,000 doses representing nearly 100% of Gillead's manufacturing capacity through September. What's the rest of the world supposed to do?

Don't miss out on the discussion!
Sign up to be notified of new comments on this topic.


Post a comment

Sorry, but further commenting on this topic has been closed.

Get the most important local news stories sent straight to your inbox daily.

After 10 years, Shalala Ramen to leave downtown Mountain View
By Elena Kadvany | 5 comments | 12,425 views

Ballot propositions have problems
By Diana Diamond | 17 comments | 2,453 views

Which City Council candidates "get" climate change?
By Sherry Listgarten | 10 comments | 1,653 views

Premarital and Couples: I’m not getting what I need. How can I get him/her to change?
By Chandrama Anderson | 1 comment | 1,156 views

Family Video Chats
By Cheryl Bac | 0 comments | 513 views